( RICS:ORMP )

News from Oramed Pharmaceuticals Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

20 Apr, 2017, 08:30 ET Oramed Granted European Patent for Combination Oral Insulin and GLP-1 Analog Capsule

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


04 Apr, 2017, 08:45 ET Journal of Diabetes Science and Technology Publishes Scientific Paper Authored by Oramed Scientists

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


22 Mar, 2017, 08:45 ET Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


21 Mar, 2017, 08:45 ET Oramed Appoints Dr. Ronald Law as Chief Strategy Officer

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of Dr....


07 Feb, 2017, 08:30 ET Oramed to Present at BIO CEO and Investor and Disruptive Growth and Healthcare Conferences

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


29 Nov, 2016, 08:30 ET Oramed's ORMD-0901 (Oral GLP-1 Analog) Found Safe and Well Tolerated in Phase Ib Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, today announced it successfully concluded a...


06 Oct, 2016, 08:45 ET Oramed Receives Additional $4 Million Milestone Payment From HTIT

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced it has received an...


19 Sep, 2016, 09:00 ET Oramed to Present at the Aegis Capital Growth Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...


07 Sep, 2016, 08:00 ET Oramed to Present at the Rodman & Renshaw Global Investment Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


02 Aug, 2016, 09:00 ET Oramed Receives Additional $4 Million Milestone Payment From HTIT

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced it has received a...


28 Jul, 2016, 08:15 ET Oramed Reports Additional Phase IIb Oral Insulin Study Data Demonstrating Significant Lowering of Glucose Levels vs Placebo

Statistically Significant Results Across Key Glycemic Endpoints  Conference Call Today at 11:00 AM ET  Oramed Pharmaceuticals Inc....


26 Jul, 2016, 09:00 ET Oramed Appoints Dr. Roy Eldor as Chief Medical Director

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today the appointment of...


21 Jun, 2016, 09:05 ET Oramed Announces $6.5 Million Milestone Payment from HTIT

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a developer of oral drug delivery systems, today announced that Hefei Tianhui...


09 Jun, 2016, 08:15 ET Oramed to Present at the American Diabetes Association 76th Scientific Sessions

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


18 May, 2016, 07:25 ET Oramed Announces Positive Top-Line Results from Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), today announced positive top-line results from its Phase IIb study, designed to evaluate the safety...


11 May, 2016, 08:15 ET Oramed Patent Being Granted in China for Oral Administration of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that an official...


28 Apr, 2016, 08:15 ET Oramed to Present at PIONEERS 2016, Presented by Joseph Gunnar

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


04 Feb, 2016, 08:15 ET Oramed to Present at the BIO CEO & Investor Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


06 Jan, 2016, 08:15 ET Oramed Pharmaceuticals' Shareholder Letter

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), today issued the following shareholder letter: Dear Shareholders,  2015...


29 Dec, 2015, 08:15 ET Oramed Announces Closing of Licensing and Investment Deal with HTIT for Oral Insulin Capsule in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced the closing of its...


30 Nov, 2015, 08:16 ET Oramed Signs up to $50 Million Licensing and Investment Agreements for Oral Insulin Capsule in China

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems,...


01 Oct, 2015, 08:15 ET Oramed to Present at the Aegis Capital Growth Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


09 Sep, 2015, 08:15 ET Oramed Completes Randomization of Over 50% of Patients in Phase IIb Oral Insulin Study

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


04 Sep, 2015, 08:15 ET Oramed to Present at the Rodman & Renshaw Global Investment Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...


05 Feb, 2015, 08:25 ET Oramed to Present at the BIO CEO & Investor Conference

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...